Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer. | Front Oncol | 2022 | 36698419 | PubTator, text mining | PubMed |
| A microarray data analysis investigating the pathogenesis and potential biomarkers of autophagy and ferroptosis in intervertebral disc degeneration. | Front Genet | 2022 | 36685932 | PubTator, text mining | PubMed |
| Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis. | Front Surg | 2022 | 36684253 | PubTator, text mining | PubMed |
| Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer. | J Oncol | 2022 | 36618075 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| Installation of electrophiles onto the C-terminus of recombinant ubiquitin and ubiquitin-like proteins. | Chem Sci | 2022 | 36605735 | PubTator, text mining | PubMed |
| Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation. | Front Cell Dev Biol | 2022 | 36589741 | PubTator, text mining | PubMed |
| Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma. | Front Mol Biosci | 2022 | 36589239 | PubTator, text mining | PubMed |
| Protein Modification Employing Non-Canonical Amino Acids to Prepare SUMOylation Detecting Bioconjugates. | Pharmaceutics | 2022 | 36559319 | PubTator, text mining | PubMed |
| Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy. | Pharmaceuticals (Basel) | 2022 | 36558920 | PubTator, text mining | PubMed |
| Circ_RNF13 Regulates the Stemness and Chemosensitivity of Colorectal Cancer by Transcriptional Regulation of DDX27 Mediated by TRIM24 Stabilization. | Cancers (Basel) | 2022 | 36551703 | PubTator, text mining | PubMed |
| AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120. | Nat Commun | 2022 | 36513627 | PubTator, text mining | PubMed |
| SUMO monoclonal antibodies vary in sensitivity, specificity, and ability to detect types of SUMO conjugate. | Sci Rep | 2022 | 36494414 | PubTator, text mining | PubMed |
| Histones and their chaperones: Adaptive remodelers of an ever-changing chromatinic landscape. | Front Genet | 2022 | 36468032 | PubTator, text mining | PubMed |
| SUMO conjugation regulates the activity of the Integrator complex. | Nucleic Acids Res | 2022 | 36454007 | PubTator, text mining | PubMed |
| Regulation of the Placental Growth Factor Mediated by Sumoylation and Expression of miR-652-3p in Pregnant Women with Early-Onset Preeclampsia. | Bull Exp Biol Med | 2022 | 36437340 | PubTator, text mining | PubMed |
| The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. | Int J Mol Sci | 2022 | 36430960 | PubTator, text mining | PubMed |
| Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma. | Front Oncol | 2022 | 36387240 | PubTator, text mining | PubMed |
| Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease. | Placenta | 2022 | 36370491 | PubTator, text mining | PubMed |
| pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation. | Nat Commun | 2022 | 36369429 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=15